WANG, FLORIAN LIFAN
 Distribuzione geografica
Continente #
NA - Nord America 102
AS - Asia 85
EU - Europa 71
SA - Sud America 10
AF - Africa 6
Totale 274
Nazione #
US - Stati Uniti d'America 96
CN - Cina 27
IT - Italia 27
SG - Singapore 23
RU - Federazione Russa 10
BR - Brasile 8
HK - Hong Kong 8
IN - India 8
IE - Irlanda 6
VN - Vietnam 6
FI - Finlandia 5
GB - Regno Unito 4
JP - Giappone 4
CA - Canada 3
DE - Germania 3
FR - Francia 3
MX - Messico 3
ZA - Sudafrica 3
AT - Austria 2
ID - Indonesia 2
NL - Olanda 2
SE - Svezia 2
AM - Armenia 1
AR - Argentina 1
BD - Bangladesh 1
BY - Bielorussia 1
CO - Colombia 1
DZ - Algeria 1
ES - Italia 1
IQ - Iraq 1
KE - Kenya 1
LB - Libano 1
LT - Lituania 1
MA - Marocco 1
PH - Filippine 1
PL - Polonia 1
RO - Romania 1
SI - Slovenia 1
TH - Thailandia 1
TR - Turchia 1
UA - Ucraina 1
Totale 274
Città #
Ashburn 18
San Jose 14
Singapore 14
Boardman 11
Beijing 9
Hong Kong 7
Dublin 6
Chicago 4
Helsinki 4
Milan 4
Tokyo 4
Turin 4
Dallas 3
Johannesburg 3
Lauterbourg 3
Los Angeles 3
Nanjing 3
San Genesio Ed Uniti 3
Seattle 3
Shanghai 3
Changsha 2
Hanoi 2
Hebei 2
Ho Chi Minh City 2
Montreal 2
Munich 2
Orem 2
Pune 2
Southend 2
Wilmington 2
Ananindeua 1
Angeles City 1
Aylmer 1
Baghdad 1
Bangkok 1
Berezniki 1
Boretto 1
Botoșani 1
Brest 1
Brotas 1
Buffalo 1
Buri 1
Capão do Cipó 1
Casablanca 1
Charlotte 1
City of London 1
Ciudad Madero 1
Ciudad Victoria 1
College Park 1
Dehradun 1
Düsseldorf 1
Goiânia 1
Houston 1
Huntington 1
Hyderabad 1
Istanbul 1
Jacksonville 1
Jakarta 1
Kyiv 1
Linköping 1
Ljubljana 1
Luoyang 1
Madrid 1
Medellín 1
Moscow 1
Nanchang 1
New Delhi 1
New York 1
Oran 1
Payakumbuh 1
Piscataway 1
Querétaro 1
Quận Ba 1
Quận Mười 1
Redondo Beach 1
Redwood City 1
Salvador 1
Santa Bárbara 1
Scottsdale 1
Solidaridad 1
Surat 1
Tianjin 1
Turku 1
Vienna 1
Vilnius 1
Warsaw 1
Yerevan 1
Água Boa 1
Totale 201
Nome #
Effects of Anacetrapib in Patients with Atherosclerotic Vascular Disease 177
NeuroChip, an updated version of the NeuroX genotyping platform to rapidly screen for variants associated with neurological diseases 56
Insufficient evidence for pathogenicity of SNCA His50Gln (H50Q) in Parkinson's disease 46
Totale 279
Categoria #
all - tutte 1.256
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.256


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222 0 0 0 0 0 0 0 0 1 1 0 0
2022/202326 0 0 0 0 1 0 0 0 5 0 16 4
2023/202422 2 3 3 2 2 2 0 0 0 1 4 3
2024/202553 4 3 0 0 1 4 6 4 10 4 7 10
2025/2026145 13 12 12 10 12 14 25 24 18 5 0 0
Totale 279